Literature DB >> 16015260

Protective role of vitamin E on the oxidative stress in Hansen's disease (Leprosy) patients.

R Vijayaraghavan1, C S Suribabu, B Sekar, P K Oommen, S N Kavithalakshmi, N Madhusudhanan, C Panneerselvam.   

Abstract

BACKGROUND: A constellation of reactive oxygen species (ROS) capable of damaging cellular constituents generated in excess during the chronic, inflammatory, neurodegenerative disease process of leprosy. The consequences of this leads to enhanced oxidative stress and lower antioxidant status. Enzymatic antioxidants provide first line defense against ROS. We have measured the levels of oxidative stress indices like lipid peroxidation (LPO), protein carbonyls together with enzymatic antioxidants in the blood samples of control and leprosy patients. Nutritional rehabilitation by way of exogenous supplementation of functionally efficient antioxidants like vitamin E reactivates the enzymatic antioxidant system and guards against the insult caused by ROS during the pathogenesis of the disease and antileprosy chemotherapy.
DESIGN: Untreated leprosy patients were selected on the basis of clinical examination and skin smear. All diagnosed untreated leprosy patients received multi drug therapy (MDT) consisting of rifampicin, dapsone and clofazimine as recommended by World Health Organization. A small number of untreated cases were selected for co-supplementation of vitamin E along with MDT. Oxidative stress indices, enzymatic and nonenzymatic antioxidant status were assayed in untreated, MDT treated and those supplemented vitamin E along with MDT. STATISTICAL
METHODS: We have compared the significance in the mean+/-s.d. values of the oxidative stress indices and the levels of antioxidants using one way analysis of variance (ANOVA) between control, untreated, MDT treated and those supplemented vitamin E with MDT and the results were significant at P < 0.05. Statistical analysis of the results suggests that oral administration of vitamin E lowers oxidative stress and augments antioxidant status in affected individuals.
RESULTS: Enhanced oxidative stress as evidenced by increased LPO and protein carbonyl in leprosy cases lowers the antioxidant status. Treatment with MDT has a limited impact on increased oxidative stress and decreased antioxidant status. Coadministration of vitamin E along with MDT decreases oxidative stress and activate the antioxidant status. DISCUSSION: The excess production of ROS as seen in leprosy cases could lead to degeneration of tissues and derangement of internal organs. The possible reason for the decreased antioxidant status in leprosy cases may be increased production of ROS, deranged liver function, and the free radical producing ability of drugs used in MDT of leprosy. Intervention with antioxidant supplementation like vitamin E prevents oxidative stress mediated through ROS and activates the net antioxidant status during the chronic course of the disease and antileprosy chemotherapy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16015260     DOI: 10.1038/sj.ejcn.1602221

Source DB:  PubMed          Journal:  Eur J Clin Nutr        ISSN: 0954-3007            Impact factor:   4.016


  6 in total

Review 1.  Pathophysiology and antioxidant status of patients with fibromyalgia.

Authors:  Riffat Iqbal; M S Mughal; Najma Arshad; Muhammad Arshad
Journal:  Rheumatol Int       Date:  2010-04-08       Impact factor: 2.631

Review 2.  A review of nutrition in neuropathic pain of leprosy.

Authors:  Michael Klowak; Andrea K Boggild
Journal:  Ther Adv Infect Dis       Date:  2022-06-01

3.  Antioxidants protect keratinocytes against M. ulcerans mycolactone cytotoxicity.

Authors:  Alvar Grönberg; Louise Zettergren; Kerstin Bergh; Mona Ståhle; Johan Heilborn; Kristian Angeby; Pamela L Small; Hannah Akuffo; Sven Britton
Journal:  PLoS One       Date:  2010-11-04       Impact factor: 3.240

4.  In Vitro Protective Effect and Antioxidant Mechanism of Resveratrol Induced by Dapsone Hydroxylamine in Human Cells.

Authors:  Rosyana V Albuquerque; Nívea S Malcher; Lílian L Amado; Michael D Coleman; Danielle C Dos Santos; Rosivaldo Sa Borges; Sebastião Aldo S Valente; Vera C Valente; Marta Chagas Monteiro
Journal:  PLoS One       Date:  2015-08-18       Impact factor: 3.240

5.  Study on the safety and efficacy of miltefosine for the treatment of children and adolescents with post-kala-azar dermal leishmaniasis in Bangladesh, and an association of serum vitamin E and exposure to arsenic with post-kala-azar dermal leishmaniasis: an open clinical trial and case-control study protocol.

Authors:  D Mondal; M G Hasnain; M S Hossain; D Ghosh; P Ghosh; H Hossain; J Baker; R Nath; R Haque; G Matlashewski; S Hamano
Journal:  BMJ Open       Date:  2016-05-17       Impact factor: 2.692

6.  Increased oxidative stress in elderly leprosy patients is related to age but not to bacillary load.

Authors:  Pedro Henrique Lopes da Silva; Katherine Kelda Gomes de Castro; Mayara Abud Mendes; Thyago Leal Calvo; Júlia Monteiro Pereira Leal; Mariana de Andréa Vilas-Boas Hacker; José Augusto da Costa Nery; Euzenir Nunes Sarno; Roberto Alves Lourenço; Milton Ozório Moraes; Flávio Alves Lara; Danuza Esquenazi
Journal:  PLoS Negl Trop Dis       Date:  2021-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.